Global Injectable Drug Delivery Systems Market Research Report 2025

Publication ID:

PB503257642

Publication Date:

March 27, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global market for Injectable Drug Delivery Systems was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Injectable drug delivery is defined as introduction of a drug or drugs in the patient by using a delivery device. Injectables allow the transport of drugs formulated in liquid form, directly in the body. Even though, they may be designed to transport the drug to specific part of the body.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Injectable Drug Delivery Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Injectable Drug Delivery Systems.
The Injectable Drug Delivery Systems market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Injectable Drug Delivery Systems market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Injectable Drug Delivery Systems manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Baxter
Becton, Dickinson
Gerresheimer
Pfizer
Schott
ELI Lilly
Novartis
Terumo
Teva Pharmaceutical
Novo Nordik
Segment by Type
Pre-filled Syringes
Auto-injectors (Syringe and Cartridge Based)
Pen Injectors
Others
Segment by Application
Hospitals & Clinics
Home Care
Others
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Injectable Drug Delivery Systems manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Injectable Drug Delivery Systems in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Injectable Drug Delivery Systems Market Overview
1.1 Product Definition
1.2 Injectable Drug Delivery Systems by Type
1.2.1 Global Injectable Drug Delivery Systems Market Value Comparison by Type (2024 VS 2031)
1.2.2 Pre-filled Syringes
1.2.3 Auto-injectors (Syringe and Cartridge Based)
1.2.4 Pen Injectors
1.2.5 Others
1.3 Injectable Drug Delivery Systems by Application
1.3.1 Global Injectable Drug Delivery Systems Market Value by Application (2024 VS 2031)
1.3.2 Hospitals & Clinics
1.3.3 Home Care
1.3.4 Others
1.4 Global Injectable Drug Delivery Systems Market Size Estimates and Forecasts
1.4.1 Global Injectable Drug Delivery Systems Revenue 2020-2031
1.4.2 Global Injectable Drug Delivery Systems Sales 2020-2031
1.4.3 Global Injectable Drug Delivery Systems Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Injectable Drug Delivery Systems Market Competition by Manufacturers
2.1 Global Injectable Drug Delivery Systems Sales Market Share by Manufacturers (2020-2025)
2.2 Global Injectable Drug Delivery Systems Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Injectable Drug Delivery Systems Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Injectable Drug Delivery Systems, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Injectable Drug Delivery Systems, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Injectable Drug Delivery Systems, Product Type & Application
2.7 Global Key Manufacturers of Injectable Drug Delivery Systems, Date of Enter into This Industry
2.8 Global Injectable Drug Delivery Systems Market Competitive Situation and Trends
2.8.1 Global Injectable Drug Delivery Systems Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Injectable Drug Delivery Systems Players Market Share by Revenue
2.8.3 Global Injectable Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Injectable Drug Delivery Systems Market Scenario by Region
3.1 Global Injectable Drug Delivery Systems Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Injectable Drug Delivery Systems Sales by Region: 2020-2031
3.2.1 Global Injectable Drug Delivery Systems Sales by Region: 2020-2025
3.2.2 Global Injectable Drug Delivery Systems Sales by Region: 2026-2031
3.3 Global Injectable Drug Delivery Systems Revenue by Region: 2020-2031
3.3.1 Global Injectable Drug Delivery Systems Revenue by Region: 2020-2025
3.3.2 Global Injectable Drug Delivery Systems Revenue by Region: 2026-2031
3.4 North America Injectable Drug Delivery Systems Market Facts & Figures by Country
3.4.1 North America Injectable Drug Delivery Systems Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Injectable Drug Delivery Systems Sales by Country (2020-2031)
3.4.3 North America Injectable Drug Delivery Systems Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Injectable Drug Delivery Systems Market Facts & Figures by Country
3.5.1 Europe Injectable Drug Delivery Systems Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Injectable Drug Delivery Systems Sales by Country (2020-2031)
3.5.3 Europe Injectable Drug Delivery Systems Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Injectable Drug Delivery Systems Market Facts & Figures by Region
3.6.1 Asia Pacific Injectable Drug Delivery Systems Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Injectable Drug Delivery Systems Sales by Region (2020-2031)
3.6.3 Asia Pacific Injectable Drug Delivery Systems Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Injectable Drug Delivery Systems Market Facts & Figures by Country
3.7.1 Latin America Injectable Drug Delivery Systems Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Injectable Drug Delivery Systems Sales by Country (2020-2031)
3.7.3 Latin America Injectable Drug Delivery Systems Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Injectable Drug Delivery Systems Market Facts & Figures by Country
3.8.1 Middle East and Africa Injectable Drug Delivery Systems Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Injectable Drug Delivery Systems Sales by Country (2020-2031)
3.8.3 Middle East and Africa Injectable Drug Delivery Systems Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Injectable Drug Delivery Systems Sales by Type (2020-2031)
4.1.1 Global Injectable Drug Delivery Systems Sales by Type (2020-2025)
4.1.2 Global Injectable Drug Delivery Systems Sales by Type (2026-2031)
4.1.3 Global Injectable Drug Delivery Systems Sales Market Share by Type (2020-2031)
4.2 Global Injectable Drug Delivery Systems Revenue by Type (2020-2031)
4.2.1 Global Injectable Drug Delivery Systems Revenue by Type (2020-2025)
4.2.2 Global Injectable Drug Delivery Systems Revenue by Type (2026-2031)
4.2.3 Global Injectable Drug Delivery Systems Revenue Market Share by Type (2020-2031)
4.3 Global Injectable Drug Delivery Systems Price by Type (2020-2031)
5 Segment by Application
5.1 Global Injectable Drug Delivery Systems Sales by Application (2020-2031)
5.1.1 Global Injectable Drug Delivery Systems Sales by Application (2020-2025)
5.1.2 Global Injectable Drug Delivery Systems Sales by Application (2026-2031)
5.1.3 Global Injectable Drug Delivery Systems Sales Market Share by Application (2020-2031)
5.2 Global Injectable Drug Delivery Systems Revenue by Application (2020-2031)
5.2.1 Global Injectable Drug Delivery Systems Revenue by Application (2020-2025)
5.2.2 Global Injectable Drug Delivery Systems Revenue by Application (2026-2031)
5.2.3 Global Injectable Drug Delivery Systems Revenue Market Share by Application (2020-2031)
5.3 Global Injectable Drug Delivery Systems Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Baxter
6.1.1 Baxter Company Information
6.1.2 Baxter Description and Business Overview
6.1.3 Baxter Injectable Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Baxter Injectable Drug Delivery Systems Product Portfolio
6.1.5 Baxter Recent Developments/Updates
6.2 Becton, Dickinson
6.2.1 Becton, Dickinson Company Information
6.2.2 Becton, Dickinson Description and Business Overview
6.2.3 Becton, Dickinson Injectable Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Becton, Dickinson Injectable Drug Delivery Systems Product Portfolio
6.2.5 Becton, Dickinson Recent Developments/Updates
6.3 Gerresheimer
6.3.1 Gerresheimer Company Information
6.3.2 Gerresheimer Description and Business Overview
6.3.3 Gerresheimer Injectable Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Gerresheimer Injectable Drug Delivery Systems Product Portfolio
6.3.5 Gerresheimer Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Company Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Injectable Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Pfizer Injectable Drug Delivery Systems Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Schott
6.5.1 Schott Company Information
6.5.2 Schott Description and Business Overview
6.5.3 Schott Injectable Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Schott Injectable Drug Delivery Systems Product Portfolio
6.5.5 Schott Recent Developments/Updates
6.6 ELI Lilly
6.6.1 ELI Lilly Company Information
6.6.2 ELI Lilly Description and Business Overview
6.6.3 ELI Lilly Injectable Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.6.4 ELI Lilly Injectable Drug Delivery Systems Product Portfolio
6.6.5 ELI Lilly Recent Developments/Updates
6.7 Novartis
6.7.1 Novartis Company Information
6.7.2 Novartis Description and Business Overview
6.7.3 Novartis Injectable Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Novartis Injectable Drug Delivery Systems Product Portfolio
6.7.5 Novartis Recent Developments/Updates
6.8 Terumo
6.8.1 Terumo Company Information
6.8.2 Terumo Description and Business Overview
6.8.3 Terumo Injectable Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Terumo Injectable Drug Delivery Systems Product Portfolio
6.8.5 Terumo Recent Developments/Updates
6.9 Teva Pharmaceutical
6.9.1 Teva Pharmaceutical Company Information
6.9.2 Teva Pharmaceutical Description and Business Overview
6.9.3 Teva Pharmaceutical Injectable Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Teva Pharmaceutical Injectable Drug Delivery Systems Product Portfolio
6.9.5 Teva Pharmaceutical Recent Developments/Updates
6.10 Novo Nordik
6.10.1 Novo Nordik Company Information
6.10.2 Novo Nordik Description and Business Overview
6.10.3 Novo Nordik Injectable Drug Delivery Systems Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Novo Nordik Injectable Drug Delivery Systems Product Portfolio
6.10.5 Novo Nordik Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Injectable Drug Delivery Systems Industry Chain Analysis
7.2 Injectable Drug Delivery Systems Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Injectable Drug Delivery Systems Production Mode & Process Analysis
7.4 Injectable Drug Delivery Systems Sales and Marketing
7.4.1 Injectable Drug Delivery Systems Sales Channels
7.4.2 Injectable Drug Delivery Systems Distributors
7.5 Injectable Drug Delivery Systems Customer Analysis
8 Injectable Drug Delivery Systems Market Dynamics
8.1 Injectable Drug Delivery Systems Industry Trends
8.2 Injectable Drug Delivery Systems Market Drivers
8.3 Injectable Drug Delivery Systems Market Challenges
8.4 Injectable Drug Delivery Systems Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Baxter
Becton, Dickinson
Gerresheimer
Pfizer
Schott
ELI Lilly
Novartis
Terumo
Teva Pharmaceutical
Novo Nordik

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂